Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	116.31B
Revenue (ttm)	17.11B
Net Income (ttm)	834.60M
Shares Out	316.16M
EPS (ttm)	2.78
PE Ratio	132.34
Forward PE	96.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	524,935
Average Volume	590,680
Open	356.05
Previous Close	354.50
Day's Range	354.55 - 370.45
52-Week Range	327.40 - 463.85
Beta	n/a
RSI	49.10
Earnings Date	May 28, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.